Regeneron is a New York biotechnology company that makes medicines for eye diseases, cancer, allergic conditions, and other serious illnesses. It last closed at $957.76 on Nov 17, up 0.56% on the day. REGN reports earnings on Thu, Jan 28, 2027. The average 12-month price target from 21 analysts is $961.52 (+0.4% from the last close), with a high of $1175.00 and a low of $812.00. Analyst consensus is Buy, based on the latest ratings from 21 firms (14 buy, 7 hold, 0 sell). Over the past 90 days StreetAlpha recorded 7 whale options trades in REGN, 43% of them bullish and 57% bearish. In the past 30 days there were 23 dark pool prints totaling $26.3M, the largest $3.7M.
Each firm's latest rating on REGN in the past 90 days
Average 12-month target
$961.52
▲ 0.4% upside
Based on 21 analysts who set a price target on REGN in the past 90 days. The average target is $961.52, with a high of $1175.00 and a low of $812.00, compared with the last close of $957.76.
Low $812.00Avg $961.52High $1175.00
Blue marker: last close $957.76
Highest target$1175.00
Average target$961.52
Lowest target$812.00
Latest rating changes
BarclaysMaintained
Nov 17Buy$1075
Leerink PartnersTarget raised
Nov 2Hold$824 → $997
BernsteinMaintained
Nov 2Hold$812
Morgan StanleyTarget raised
Nov 2Hold$779 → $855
RBC CapitalTarget raised
Nov 2Hold$810 → $913
Date
Firm
Action
Rating
Price target
Nov 17
Barclays
Maintained
Buy
$1075
Nov 2
Leerink Partners
Target raised
Hold
$824 → $997
Nov 2
Bernstein
Maintained
Hold
$812
Nov 2
Morgan Stanley
Target raised
Hold
$779 → $855
Nov 2
RBC Capital
Target raised
Hold
$810 → $913
Loading…
Technical Analysis
REGN · as of the Nov 17 close · updated after every close
Uptrend, nearing overbought
The stock is 7% above its 20 day and 14% above its 50 day average. It is 22% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 68), near overbought. The nearest support is the Pivot at $956.73, and the nearest resistance the Pivot R1 at $966.51.
Short trendBullish
Long trendBullish
MomentumStrong
StretchNear overbought
VolatilityHigh, 3.2%/day
Key levels
$991.7352 week high+3.5%
$981.55Swing high (Nov 12)+2.5%
$966.51Pivot R1+0.9%
$957.76Last close
$956.73Pivot−0.1%
$947.97Pivot S1−1.0%
$894.9120 day average−6.6%
$887.22Swing low (Nov 6)−7.4%
$821.6150 day average−14.2%
$781.51100 day average−18.4%
$748.97200 day average−21.8%
$591.5252 week low−38.2%
Indicators
RSI (14)
68.25
Strong, overbought above 70
Neutral
MACD
42.26
Above its signal line
Bullish
Stochastic
80.4
Near the top of its range
Overbought
ADX (14)
39.4
Trending up
Williams %R
-18.9
Oversold below −80, overbought above −20
Overbought
CCI (20)
73.5
Oversold below −100, overbought above 100
Neutral
Rate of change
−1.6%
Change over 10 sessions
Bearish
ATR (14)
$30.45
Typical daily range, 3.2% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
Rising, nearing overbought
Short trendBullish
Long trendNot enough history
MomentumStrong
StretchNear overbought
VolatilityNormal, 6.0%/day
Key levels
$991.7352 week high+3.5%
$981.55Swing high (Nov 12)+2.5%
$966.51Pivot R1+0.9%
$957.76Last close
$956.73Pivot−0.1%
$947.97Pivot S1−1.0%
$894.9120 day average−6.6%
$887.22Swing low (Nov 6)−7.4%
$821.6150 day average−14.2%
$781.51100 day average−18.4%
$748.97200 day average−21.8%
$591.5252 week low−38.2%
Indicators
RSI (14)
69.72
Strong, overbought above 70
Neutral
MACD
54.83
Above its signal line
Bullish
Stochastic
80.5
Near the top of its range
Overbought
ADX (14)
35.6
Trending up
Williams %R
-12.6
Oversold below −80, overbought above −20
Overbought
CCI (20)
176.6
Oversold below −100, overbought above 100
Overbought
Rate of change
+22.6%
Change over 10 sessions
Bullish
ATR (14)
$57.43
Typical daily range, 6.0% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200–
What happened before, for REGN
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how REGN did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
Whale flow is mixed3 bullish and 4 bearish whale options trades in the last 90 days. See Whale Flow
November seasonalityHow REGN usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How REGN has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.
From the company's 10-Q filed Oct 30, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether REGN is in one of them and how their past REGN trades turned out.
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Regeneron Pharmaceuticals
Regeneron is a biotechnology company based in Tarrytown, New York. It discovers, develops, makes, and sells medicines for people with serious diseases. Its products and product candidates address conditions such as eye disorders, allergic and inflammatory diseases, cancer, and cardiovascular and metabolic diseases. The company also covers neurological diseases, blood conditions, infectious diseases, and rare diseases. Its customers include patients and medical professionals.